Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABLE: Nitrofurantoin for Asymptomatic Bacteriuria in Pregnancy
NCT06723392Phase 3Recruiting
- Sponsor
- Global Network for Women's and Children's Health Research
- Start
- Dec 2025
- Primary completion
- Sep 2028
- Modality
- Metabolically Activated Prodrugs
- Countries
- 6
01
Overview
Phase 3, randomised trial in asymptomatic bacteriuria (ASB) comparing Oral nitrofurantoin monohydrate/macrocrystals with Placebo (2 arms). Primary endpoint: Small Vulnerable Newborn or Stillbirth. Started Dec 2025; status: recruiting.
02
Drugs
nitrofurantoin
03
Conditions
asymptomatic bacteriuria (ASB)
Beyond the preview
Go deeper on NCT06723392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06723392.